D. Keith Grossman

Insider profile

Currently holds positions in Outset Medical Inc, ViewRay Inc, Bayer Essure Inc and Alcon AG

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Outset Medical Inc None -
Independent Director ViewRay Inc July 1, 2018 -
President, Chief Executive Officer Bayer Essure Inc June 5, 2013 -
Vice Chairman of the Board, Senior Independent Director Alcon AG None -
Lead Independent Director ZELTIQ Aesthetics Inc Feb. 1, 2016 - April 28, 2017
Independent Director ZELTIQ Aesthetics Inc Oct. 24, 2013 - Feb. 1, 2016
President, Chief Executive Officer, Director Thoratec Corp Sept. 22, 2014 - Oct. 8, 2015
Independent Director Thoratec Corp Jan. 17, 2006 - Sept. 22, 2014
President, Chief Executive Officer, Director Bayer Essure Inc Dec. 8, 2011 - June 5, 2013
D. Keith Grossman's trades of Outset Medical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
201.61
Quantity 98,679
Value US$1,792,457
Transaction date
Planned sale
Price
71.38
Quantity 11,658 +42.8%
Value US$2,959,637
Transaction date
Planned sale
Price
277.53
Quantity 2,044 +1.6%
Value US$4,847,695
US Nevro Corp (NVRO)
Transaction date
Purchase
Price
63.59
Quantity 3,200 +1.9%
Value US$203,488
Transaction date
Planned sale
Price
47.92
Quantity 1,296 -20.0%
Value US$62,104
Transaction date
Planned sale
Price
54.31
Quantity 1,296 -16.7%
Value US$70,386
Transaction date
Planned sale
Price
55.00
Quantity 2,592 -25.0%
Value US$142,560
Transaction date
Planned sale
Price
49.69
Quantity 1,234 -37.5%
Value US$61,317
Transaction date
Planned sale
Price
49.69
Quantity 62 -1.9%
Value US$3,081
Transaction date
Planned sale
Price
55.00
Quantity 1,296 -28.3%
Value US$71,280
Transaction date
Planned sale
Price
55.00
Quantity 1,296 -28.3%
Value US$71,280
Transaction date
Planned sale
Price
55.00
Quantity 1,296 -28.3%
Value US$71,280
Transaction date
Planned sale
Price
55.00
Quantity 1,296 -28.3%
Value US$71,280
US Nevro Corp (NVRO)
Transaction date
Purchase
Price
105.07
Quantity 7,000 +5.9%
Value US$735,490
Transaction date
Planned sale
Price
47.92
Quantity 1,296 -100.0%
Value US$62,102
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-03 2024-06-03
PrS Proposed sale
98,679
201.61
US$1,792,457 		98,679 201.61 US$1,792,457
2024-06-03 2024-06-03
PlS Planned sale
11,658 +42.8%
71.38
US$2,959,637 		11,658 +42.8% 71.38 US$2,959,637
2024-06-03 2024-06-03
PlS Planned sale
2,044 +1.6%
277.53
US$4,847,695 		2,044 +1.6% 277.53 US$4,847,695
2022-03-08 2022-03-08
US Nevro Corp (NVRO)
B Purchase
3,200 +1.9%
63.59
US$203,488 		3,200 +1.9% 63.59 US$203,488
2021-12-02 2021-12-01
PlS Planned sale
1,296 -20.0%
47.92
US$62,104 		1,296 -20.0% 47.92 US$62,104
2021-11-02 2021-11-01
PlS Planned sale
1,296 -16.7%
54.31
US$70,386 		1,296 -16.7% 54.31 US$70,386
2021-11-02 2021-11-01
PlS Planned sale
2,592 -25.0%
55.00
US$142,560 		2,592 -25.0% 55.00 US$142,560
2021-10-04 2021-10-01
PlS Planned sale
1,234 -37.5%
49.69
US$61,317 		1,234 -37.5% 49.69 US$61,317
2021-10-04 2021-10-01
PlS Planned sale
62 -1.9%
49.69
US$3,081 		62 -1.9% 49.69 US$3,081
2021-10-04 2021-09-17
PlS Planned sale
1,296 -28.3%
55.00
US$71,280 		1,296 -28.3% 55.00 US$71,280
2021-10-04 2021-09-17
PlS Planned sale
1,296 -28.3%
55.00
US$71,280 		1,296 -28.3% 55.00 US$71,280
2021-10-04 2021-09-17
PlS Planned sale
1,296 -28.3%
55.00
US$71,280 		1,296 -28.3% 55.00 US$71,280
2021-10-04 2021-09-17
PlS Planned sale
1,296 -28.3%
55.00
US$71,280 		1,296 -28.3% 55.00 US$71,280
2021-08-17 2021-08-13
US Nevro Corp (NVRO)
B Purchase
7,000 +5.9%
105.07
US$735,490 		7,000 +5.9% 105.07 US$735,490
2021-06-02 2021-06-01
PlS Planned sale
1,296 -100.0%
47.92
US$62,102 		1,296 -100.0% 47.92 US$62,102